Human metastatic prostate PC3 cell lines degrade bone using matrix metalloproteinases

Invasion and Metastasis

Volumn 18, Issue 5-6, 1998, Pages 297-305

  Sanchez Sweatman, Otto H ^a   Orr, F William ^b   Singh, Gurmit ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Bone; Matrix metalloproteinases; Osteolysis

Indexed keywords

MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE; BONE MATRIX; BONE METASTASIS; CANCER CELL CULTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOCYTE; OSTEOLYSIS; PROSTATE ADENOCARCINOMA;

EID: 0032467396     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024522     Document Type: Article

References (45)

1. Kanis JA: Bone and cancer: Pathophysiology and treatment of metastases. Bone 1995;17:101S-105S.
2. Eilon G, Mundy GR: Direct resorption of bone by human breast cancer cells in vitro, nature 1978;276:726-728.
3. Athanasou NA, Quinn JMW: Human tumour-associated macrophages are capable of bone resorption. Br J Cancer 1992;65:523-526.
4. Garrett IR: Bone destruction in cancer. Semin Oncol 1993;20:4-9.
5. Ohishi K, Fujita N, Morinaga Y, Tsuruo T: H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption. Clin Exp Metastasis 1995;13:287-295.
6. Shivas AA, Black JW, Finlayson ND: The growth of Brown-Pearce carcinoma in the medullary cavity of the rabbit femur. Br J Cancer 1963;17:711-714.
7. Koeffler HP, Mundy GR, Golde DW, Cline MJ: Production of bone resorbing activity in poorly differentiated monocytic malignancy. Cancer 1978;41:2438-2443.
8. Mundy GR, Eilon G, Altman AJ, Dominguez JH: Non-bone cell mediated bone resorption: in Horton JE, Tarpley TM, Davis WF (eds): Mechanisms of Localized Bone Loss. Arlington, Information Retrieval, 1978, pp 229-237.
9. Eilon G, Mundy GR: Association of increased cyclic adenosine 3′:5′-monophosphate content in cultured human breast cancer cells and release of hydrolytic enzymes and bone-resorbing activity. Cancer Res 1983;43:5792-5794.
10. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M: Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: Implications for bone résorption. Lab Invest 1995;72:311-322.
11. Meikle MC, Bord S, Hembry RM, Reynolds JJ: The synthesis of collagenase, gelatinase-A (72 kDa) and -B (95 kDa), and TIMP-1 and -2 by human osteoblasts from normal and arthritic bone. Bone 1995;17:255-260.
12. DeClerck YA, Shimada H, Taylor SM, Langley KE: Matrix metalloproteinases and their inhibitors in tumour progression. Ann NY Acad Sci 1994;732:222-232.
13. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig Urol 1979;17:16-23.
14. Biedler JL, Helson L, Spengler BA: Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973;33:2643-2652.
15. Owens RB, Smith HS, Nelson-Rees WA, Springer EL: Epithelial cell cultures from normal and cancerous human tissues. J Natl Cancer Inst 1976;56:843-849.
16. Smith HS: In vitro properties of epithelial cell lines established from human carcinomas and nonmalignant tissue. J Natl Cancer Inst 1979;62: 225-230.
17. Ponten J, Saksela E: Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 1967;2:434-447.
18. Rifas L, Fausto A, Scott MJ, Avioli LV, Welgus HG: Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: Differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology 1994;134:213-221.
19. Kostenuik PJ, Sanchez-Sweatman OH, Orr FW, Singh G: Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin. Clin Exp Metastasis 1996;14:19-26.
20. Gospodarowicz D, Lepine J, Massoglia S, Wood I: Comparison of the ability of basement membranes produced by corneal endothelial and mouse-derived endodermal PF-HR-9 cells to support the proliferation and differentiation of bovine kidney tubule epithelial cells in vitro. J Cell Biol 1984;99:947-961.
21. Magro C, Orr FW, Manishen WJ, Sivananthan K, Mokashi SS: Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone. J Natl Cancer Inst 1985;74: 829-838.
22. Chambers TJ, Revell PA, Fuller K, Athanasou NA: Resorption of bone by isolated rabbit osteoclasts. J Cell Sci 1984;66:383-399.
23. Ritchie CK, Maercklein PB, Fitzpatrick LA: Direct effect of calcium channel antagonists on osteoclast function: Alterations in bone resorption and intracellular calcium concentrations. Endocrinology 1994; 135:996-1003.
24. Merz WA, Schenk RK: Quantitative structural analysis of human cancellous bone. Acta Anat 1970;75:54-66.
25. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202.
26. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Preparation and analysis of RNA; in Current Protocols in Molecular Biology. New York, Wiley, 1991, pp 401-428.
27. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 1986; 261:6600-6605.
28. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP: Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumour and normal cell lines. Invasion Metastasis 1992;12:168-184.
29. Ossowski L: Invasion of connective tissue by human carcinoma cell lines: Requirement for urokinase, urokinase receptor, and interstitial collagenase. Cancer Res 1992;52: 6754-6760.
30. Kostenuik PJ, Singh G, Orr FW: Transforming growth factor beta upregulates the integrin-mediated adhesion of human prostatic carcinoma cells to type I collagen. Clin Exp Metastasis 1997;15:41-52.
31. Denhardt DT, Rajan S, Walther SE: Structure-function studies of mouse tissue inhibitor of metalloproteinases-1. Ann NY Acad Sci 1994; 732:65-74.
32. Gack S, Vallon R, Schaper J, Ruther U, Angel P: Phenotypic alterations in fos-transgenic mice correlate with changes in fos/jun-dependent collagenase type I expression. Regultion of mouse metalloproteinases by carcinogens, tumour promoters, cAMP, and fos oncoprotein. J Biol Chem 1994;269:10363-10369.
33. Teitelbaum SL, Ross FP: Mechanisms of tumour-induced osteolysis. Lab Invest 1994;71:453-455.
34. Quinn JMW, Matsumura Y, Tarin D, McGee JOD, Athanasou NA: Cellular and hormonal mechanisms associated with malignant bone resorption. Lab Invest 1994;71:465-471.
35. Grundmann E, Roessner A, Ueda Y, Schneider-Stock R, Radig K: Current aspects of the pathology of osteosarcoma. Anticancer Res 1995; 15:1023-1033.
36. Cockett MI, Birch ML, Murphy G, Hart IR, Docherty AJP: Metalloproteinase domain structure, cellular invasion and metastasis. Biochem Soc Trans 1994;22:55-57.
37. Furcht LT, Skubitz APN, Fields GB: Tumour cell invasion, matrix metalloproteinases, and the dogma. Lab Invest 1994;70:781-783.
38. Pauli BU, Knudson W: Tumour invasion: A consequence of destructive and compositional matrix alterations. Hum Pathol 1988;19:628-639.
39. Woessner JF Jr: The family of matrix metalloproteinases. Ann NY Acad Sci 1994;732:11-21.
40. Aimes RT, Quigley JP: Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem 1995;270: 5872-5876.
41. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P, Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6:1899-1904.
42. Centrella M, Horowitz MC, Wozney JM, McCarthy TL: Transforming growth factor-beta gene family members and bone. Endocr Rev 1994;15:27-39.
43. Matrisian LM, Ganser GL, Kerr LD, Pelton RW, Wood LD: Negative regulation of gene expression by TGF-beta. Mol Reprod Dev 1992; 32:111-120.
44. Samuel SK, Hurta RAR, Kondaiah P, Khalil N, Turley EA, Wright JA, Greenberg AH: Autocrine induction of tumour protease production and invasion by a metallothionein-regulated TGF-betal (Ser223, 225). EMBO J 1992;11:1599-1605.
45. Hill PA, Reynolds JJ, Meikle MC: Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim Biophys Acta 1993;1177:71-74.